Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Moodys
Chubb
Julphar
Deloitte
McKinsey
Teva
Novartis
Boehringer Ingelheim
McKesson

Generated: August 21, 2017

DrugPatentWatch Database Preview

Norethindrone acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for norethindrone acetate and what is the scope of norethindrone acetate patent protection?

Norethindrone acetate
is the generic ingredient in three branded drugs marketed by Duramed Res, Aurobindo Pharma Ltd, Barr, Amneal Pharms, Mylan Labs Ltd, Parke Davis, and Glenmark Generics, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for norethindrone acetate. Nine suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: norethindrone acetate

Tradenames:3
Patents:0
Applicants:7
NDAs:7
Drug Master File Entries: see list26
Suppliers / Packagers: see list9
Bulk Api Vendors: see list58
Clinical Trials: see list945
Patent Applications: see list3,162
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:norethindrone acetate at DailyMed

Pharmacology for Ingredient: norethindrone acetate

Ingredient-typeProgesterone Congeners
Drug ClassProgestin

Tentative approvals for NORETHINDRONE ACETATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe1MG;0.01MG;75MGTABLET;ORAL
► Subscribe► Subscribe1MG;0.02MGTABLET;ORAL
► Subscribe► Subscribe75MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL205278-001Nov 10, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
NORLUTATE
norethindrone acetate
TABLET;ORAL012184-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Res
AYGESTIN
norethindrone acetate
TABLET;ORAL018405-001Apr 21, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Glenmark Generics
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL091090-001Jul 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL075951-001May 25, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Colorcon
Healthtrust
Express Scripts
Daiichi Sankyo
Chubb
Cipla
Fuji
Federal Trade Commission
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot